After the eligibility check of the proposals submitted to the CoLAB AccelBio - Open Call 2024, 22 proposals were evaluated by three reviewers each. The proposals then moved to the second phase: the interview. Based on the combined grades from both stages, the projects FATLOSS and COMASLINK were selected for support by CoLAB AccelBio. We would like to express our gratitude to all participants for their hard work and innovative ideas. Your contributions are highly valued, and we encourage you to continue pursuing your groundbreaking projects.
The table with the final scores of each eligible project is available here:

We are thrilled to announce the launch of the AccelBio Open Call, a competition aimed at accelerating biomedical innovation in Portugal. Our primary mission is to facilitate the successful transfer of scientific knowledge to the economy by fostering the development of products and businesses in drug discovery.

Objective: The AccelBio Open Call seeks to identify and support projects with the most promising prospects of transitioning from research into clinical product candidates. Our ultimate goal is to capitalize on the best Portuguese discoveries and transform them into innovative drug assets.

Focus Areas: We invite proposals from Portuguese public or non-profit legal entities, including universities, research centers, and hospitals. Eligible projects should have potential as pharmaceutical therapies, particularly in the following therapeutic areas:

• Oncology
• Neurosciences
• Infectious diseases
• Immunology
• Metabolism
• Cardiovascular

Support Offered: Selected projects will receive a financial award of up to 50,000€ to cover services and consumables. Additionally, we will provide assistance in preparing a comprehensive value creation plan. This plan, developed with the support of the AccelBio team, will have a duration of 18 months and will encompass a series of experiments necessary to drive a drug discovery project effectively to the pre-clinical candidate stage.

How to Apply: Interested parties are invited to submit proposals outlining their research activity and its potential to be developed into assets with clinical therapeutic potential.

Submission Deadline (Extended): The deadline for proposal submission is April 14^th, 2024

Join Us in Transforming Scientific Ideas into Clinical Solutions: We believe that collaboration and innovation are key drivers of progress in biomedical research. By participating in the CoLAB AccelBio Open Call, you will have the opportunity to contribute to the advancement of healthcare and make a meaningful impact on patients' lives.

For more information and to submit your proposal, please check the Guidelines and the Application Template.

Let's accelerate biomedical innovation together!